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In this study, kinetics of attachment and internalization of feline infectious peritonitis virus (FIPV)
serotype I strain Black and serotype II strain 79-1146 were determined in feline monocytes from
two cats and in Crandell feline kidney (CrFK) cells. Attached FIPV I (Black) particles were
observed on almost all monocytes. Within 1 h, 17 particles were bound per cell and, within 1 min,
89% of the bound particles were internalized. For FIPV II (79-1146), attachment was observed
on 66 and 95% of all monocytes from the two cats. After 1 h, respectively five and 20 particles
were bound per cell (all cells considered). Within 1 min, 60% of the bound particles were
internalized. Internalization in monocytes was efficient and proceeded via endocytosis. In CrFK
cells, attachment and internalization were less efficient, especially for FIPV I (Black), so this cell
line is not suitable for studying FIPV entry.
Feline infectious peritonitis virus (FIPV) is a coronavirus
belonging to the order Nidovirales (Cavanagh, 1997;
Cowley et al., 2000; Gorbalenya et al., 2006). Based on
comparative sequence analysis, human coronavirus 229E
(HCoV 229E), porcine transmissible gastroenteritis virus
(TGEV), porcine epidemic diarrhea virus, canine corona-
virus (CCoV) and feline coronaviruses (FCoV) are grouped
in phylogenetic group 1 (Gonza´lez et al., 2003; Spaan et al.,
2005; Gorbalenya et al., 2006). Feline coronaviruses are
divided into two serotypes: serotype I and the less prevalent
serotype II (Pedersen et al., 1984; Hohdatsu et al., 1992).
Type II strains are related closely to CCoV and TGEV
(Pedersen et al., 1983) and are thought to be recombinants
of type I strains and CCoV (Vennema et al., 1995). Unlike
type I strains, type II strains grow easily in cell culture, such
as Crandell feline kidney (CrFK) cells, and are therefore
used frequently in FIPV studies.
Aminopeptidase N (APN) serves as a receptor for several
group 1 coronaviruses (Tresnan et al., 1996), including
HCoV 229E (Yeager et al., 1992), porcine respiratory
coronavirus and TGEV (Delmas et al., 1992, 1993, 1994).
For both serotype I and II FCoVs, stably expressed APN
cDNA isolated from the Felis catus whole fetus (fcwf)
cell line induced susceptibility in FCoV-resistant cells.
Although strains of both serotypes were able to infect these
cells, the efficiency of infection was different (Tresnan et al.,
1996). Hohdatsu et al. (1998) showed that only serotype II
strains of FCoV use feline APN (fAPN) as a receptor for
internalization into feline cell lines. Infection of bone
marrow-derived macrophages with FIPV II (79-1146) was
restricted from approximately 33 to 3% of cells by a mAb
against fAPN (Rottier et al., 2005). Whether fAPN is the
receptor for FIPV II on in vivo target cells, feline blood
monocytes, is not known. The receptor for FIPV I has not
been identified.
Viruses may enter cells via two pathways. Viral envelopes
may fuse with the plasma membrane or with endosomal
membranes after entering cells via endocytosis. Several
group 1 coronaviruses enter cells via endocytosis: HCoV
229E (Nomura et al., 2004), TGEV (Hansen et al., 1998)
and CCoV (Savarino et al., 2003). Mouse hepatitis virus, a
group 2 coronavirus, enters cells by both endosomal and
non-endosomal pathways. The pathway of internalization
was shown to depend upon the virus strain and the nature
of the cell being infected (Kooi et al., 1991; Nash &
Buchmeier, 1997). Internalization of FIPV has not been
studied in either primary cells or cell lines.
In this study, kinetics of attachment and internalization
were studied for FIPV in feline blood monocytes, the
primary target cells, and compared with those in CrFK
cells, used frequently as a model cell line for FCoV–cell
interactions. Further, it was investigated whether FIPV
enters monocytes and CrFK cells via fusion with the plasma
membrane or via endocytosis.
Monocytes were isolated from blood collected from two
FCoV-, feline leukemia virus- and feline immunodeficiency
virus-negative cats as described previously (Dewerchin
et al., 2005) and seeded on glass coverslips. The adherent
A figure showing co-localization of biotinylated particles and FIPV virions
is available with the online version of this paper.
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cells consisted of 86±7% monocytes [assessed with mono-
cyte marker DH59B; Veterinary Medical Research and
Development (VMRD)]. Experiments were performed at
36 h post-seeding, using third passages of type I FIPV
strain Black (Black, 1980) on fcwf cells and third passages
of type II FIPV strain 79-1146 (McKeirnan et al., 1981) on
CrFK cells. Both strains were kindly provided by Dr H. F.
Egberink (Utrecht University, The Netherlands). Virus
purification was performed as described by Delputte et al.
(2002) and Delputte & Nauwynck (2004). Purified virus
was biotinylated with Sulfo-NHS-LC-Biotin (Pierce)
according to the manufacturer’s instructions. Purified
viral-particle suspension (200 mg) was applied to 104.4
monocytes or 106 CrFK cells throughout the experiments.
Application of diluted samples of biotinylated virus
suspension to streptavidin-coated coverslips (Xenopore)
and staining with fluorescein isothiocyanate (FITC)-
labelled streptavidin (Molecular Probes) showed that
this amount of virus contains 7.96109 FIPV I (Black)
particles and 5.061010 FIPV II (79-1146) particles. Double
staining with polyclonal anti-FIPV–FITC (VMRD) and
streptavidin–Texas red (Molecular Probes) confirmed the
concurrence of biotin and FIPV antigens (see Supple-
mentary Fig. S1, available in JGV Online). Further, it was
shown that the biotinylation procedure did not influence
the obtained kinetics (data not shown). Cell vitality was
checked at the end of the experiments. Triplicate assays
were performed and kinetics were compared by using the
Wilcoxon signed ranks (WSR) test from the SPSS software
package (version 12.0; SPSS Inc.).
To determine kinetics of attachment, cells were chilled on
ice for 15 min and inoculated with biotinylated FIPV I
(Black) or II (79-1146) at 4 uC. At different time points,
cells were washed with PBS and fixed with 1% formalde-
hyde. Attached particles were visualized by using FITC-
labelled streptavidin and counted manually for 50
randomly chosen cells by means of a DM IRB inverted
microscope (Leica). Fig. 1(a) illustrates the origin of the
graphs shown in Fig. 1(b). FIPV I (Black) bound to almost
all monocytes (98.8% of the monocytes for cat 1 and
99.5% for cat 2). For cat 1, the number of attached
Fig. 1. Kinetics of attachment. (a) Cells were
inoculated with biotinylated FIPV and incu-
bated at 4 6C. At designated time points, virus
was visualized by using streptavidin–FITC. (b)
Dotted lines depict time courses determined in
three independently performed experiments;
the solid line depicts the mean time course
based on these three experiments.
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particles per cell reached 14±1 after 15 min; for cat 2, it
was 18±1 after 1 h. Thereafter, no further increase was
observed. Attachment to CrFK cells was restricted to 15.4%
of the cells and, after 2 h, only 1±1 particle was bound per
cell (all cells considered). FIPV II (79-1146) bound to only
66.2% of the monocytes for cat 1 and to 95.0% for cat 2.
For cat 1, the number of attached particles per cell increased
slowly to 5±3 during the first hour. For cat 2, a strong
increase to 19±10 particles per cell was observed during
the first 30 min. Afterwards, attachment remained at the
same level. Clearly, cat 2 reached a higher level of attached
FIPV II (79-1146) particles than cat 1. In contrast to the
results for FIPV I (Black), almost all CrFK cells (99.8%)
bound FIPV II (79-1146) particles. Also, more particles
were attached, although the kinetics were slow. During
4 h incubation, the number of bound particles per cell
increased gradually to 49±19. Longer incubation times
increased the amount of bound virus slightly. Based on the
numbers of inoculated and attached virus particles, it is
clear that virus was present in excess in all experiments. So,
for both FIPV I (Black) and II (79-1146), all possible
binding sites were taken.
To determine the kinetics of entry, cells were incubated
with virus until the maximum number of attached particles
was reached, i.e. 1 h for incubation of monocytes with both
strains, and 2 and 5 h for incubation of CrFK cells with
respectively FIPV I (Black) and FIPV II (79-1146) (Fig. 1).
Cells were washed and plates were transferred from 4 to
37 uC (time point zero for the kinetics of internalization).
Then, cells were fixed at different time points. Attached
particles were visualized by using streptavidin–Texas red.
After permeabilizing cells with 0.1% Triton X-100, inter-
nalized particles were stained with streptavidin–FITC.
Kinetics of internalization are shown in Fig. 2. The percent-
ages given were calculated by quantifying particles inside
the cytosol and on the surface of 10 cells with attached and/
or internalized particles. The kinetics of internalization for
FIPV I (Black) in monocytes were similar for both cats.
Almost all monocytes that bound FIPV I (Black) virions
Fig. 2. Kinetics of internalization. (a) Cells
were inoculated with biotinylated FIPV and
incubated at 4 6C until saturation of attach-
ment. Plates were then transferred to 37 6C.
At designated time points, virus at the plasma
membrane was visualized by using strept-
avidin–Texas red and, after permeabilization,
internalized virus was visualized by using
streptavidin–FITC. (b) Dotted lines depict time
courses determined in three independently
performed experiments; the solid line depicts
the mean time course based on these three
experiments.
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internalized virions (98.9% of the monocytes for cat 1 and
98.5% for cat 2). Remarkably, immobilization of the cells
at 4 uC could not inhibit internalization completely, as
there were already particles internalized at time point zero.
Within the first minute, 89±6% of the bound particles
were internalized per cell. This level of internalization was
roughly maintained, although a slight, not significant,
decrease to 85±13% was observed after 1 h. However,
unlike for monocytes, uptake was restricted in CrFK cells
to 20.8% of the cells that had bound virus or only 3.2% of
all cells. No internalization was observed after the first
minute, but during the first 2 h, kinetics gradually increased
to a maximum, with 52% of the bound particles inter-
nalized per cell. The percentages of internalized particles
per cell varied between 0 and 100%, as often only one
particle was bound, so only one particle could be internal-
ized. As for FIPV I (Black), internalization of FIPV II (79-
1146) was mediated by nearly all monocytes that had
bound virus particles (92.5% of the analysed monocytes
from cat 1 and all analysed monocytes from cat 2) and
kinetics were similar for both cats. After 1 min, a mean of
60±9% of the bound virions were internalized per cell.
Internalization further increased gradually up to 90±7%
after 1 h. All CrFK cells were capable of internalizing FIPV
II (79-1146) virions. Within the first minute, only 3±2%
of the bound particles were internalized. However, the
percentage of internalization per cell increased gradually to
67±4% after 2 h. Longer incubation times increased the
percentage of internalization per cell only slightly.
The kinetics of internalization indicate that the majority of
bound FIPV particles enter cells via endocytosis, as bio-
tinylated envelopes were present inside the cell. However, a
small fraction of biotinylated material remained outside
the cell. This could be bound virus particles, unable to
enter the cell, or biotinylated envelopes, left behind after
fusion with the host-cell membrane. To determine the
nature of the material left at the plasma membrane, cells
were chilled on ice, inoculated and incubated at 4 uC. After
attachment, cells were shifted to 37 uC. Cells were fixed
when maximal uptake was reached (after 1 and 2 h incuba-
tion at 37 uC for monocytes and CrFK cells, respectively)
and remaining material at the plasma membrane was
stained with polyclonal anti-FIPV–FITC. After permeabil-
izing cells, nucleocapsid proteins were stained with the
mAb E22-2 (kindly provided by Dr T. Hohdatsu, Kitasato
University, Japan) and visualized with goat anti-mouse–
Texas red (Molecular Probes). Fig. 3 shows that all FIPV
material at the plasma membrane co-localized with nucleo-
capsid proteins. Thus, the biotinylated material consisted
of intact virions. This implies that, under the present
experimental conditions, both FIPV strains enter mono-
cytes exclusively via endocytosis, and FIPV II (79-1146)
also does so in CrFK cells.
In this study, the initial steps in FIPV infection were
analysed in target cells by determining kinetics of attach-
ment and internalization. Kinetics of attachment for FIPV
II (79-1146) were significantly different between the two
cats (P50.025; WSR). This difference could be the
Fig. 3. Co-localization of non-internalized
biotinylated material and FIPV nucleocapsid
protein. Confocal images of monocytes and
CrFK cells that were incubated at 4 6C, then
transferred to and left at 37 6C until uptake
was completed are shown. Biotinylated mater-
ial was stained with a-FIPV–FITC and nucleo-
capsid protein with mAb E22-2 and goat a-
mouse–Texas red.
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consequence of variable expression levels of a cellular
component involved in attachment, e.g. a specific serotype
II FIPV receptor. Another difference in kinetics of attach-
ment was observed between FIPV I (Black) and FIPV II
(79-1146) for the monocytes of cat 1 (P50.012; WSR) and
cat 2 (P50.036; WSR). This could indicate that type I and
II strains use different receptors on monocytes and that
the serotype II receptor may be expressed differentially
between cats, whereas the serotype I receptor is apparently
not. Differences in receptor between type I and II have
previously been demonstrated in cell culture (Hohdatsu
et al., 1998). As only two cats were considered, these data
cannot lead to general conclusions. Further research will
focus on the receptors of FIPV in monocytes, which will
allow interpretation of the present findings.
Internalization in monocytes was very efficient for both
serotypes and was mediated exclusively by endocytosis. The
efficiency of internalization of TGEV and HCoV 229E, also
group 1 coronaviruses, and of porcine reproductive and
respiratory syndrome virus (PRRSV), another member of
the order Nidovirales, in macrophages is comparable to
that of FIPV in monocytes (Hansen et al., 1998; Nauwynck
et al., 1999; Nomura et al., 2004). Other mutual observa-
tions between TGEV, PRRSV and FIPV are the accumula-
tion of particles in endosomes (already occurring 15 min
after the start of virus uptake for FIPV) and the decreasing
number of particles inside the cell, due to particle dis-
assembly, at later time points in the kinetics (within 1 h for
FIPV). The decreasing number of particles explains the
apparent drop in internalization described for FIPV I
(Black), where the percentages of uptake per cell were
higher after 1 min than after 1 h.
Replication of FIPV is limited to a small fraction (,1% for
FIPV 79-1146) of monocytes (Dewerchin et al., 2005) and
peritoneal macrophages (Morahan et al., 1985; Stoddart &
Scott, 1989). However, virus binding and uptake took place
in almost all monocytes. Thus, the mechanism behind the
resistance of most monocytes/macrophages must lie in
inhibition of genome release and/or translation. Similar
observations were obtained for PRRSV replication in
alveolar macrophages (Duan et al., 1997; Nauwynck et al.,
1999).
Attachment and internalization of FIPV I (Black) in CrFK
cells were very inefficient. It is possible that no specific
mechanism is involved. Particles may accidentally co-
internalize with other compounds. The ability of FIPV I
(Black) to induce infection of CrFK cells was restricted
to only 0.003% of the cells at 12 h post-inoculation.
Infectivity of FIPV I (Black) in CrFK cells is the subject of
contradictory literature. Black (1980) reported suscept-
ibility of CrFK cells, whereas Hohdatsu et al. (1998) failed
to induce infection. It is possible that susceptibility of CrFK
cells may differ due to genetic changes during long-term
subpassaging. CrFK cells are often used as a model cell line
for FIPV serotype II infection studies. However, inter-
nalization of FIPV II (79-1146) was slower and less efficient
than in monocytes. Thus, FIPV seems to interact differently
with CrFK cells and with monocytes. This confirms earlier
observations (Dewerchin et al., 2005). It is concluded that
the CrFK cell line is not suitable for studying FIPV entry
into target cells.
The findings concerning attachment and internalization in
monocytes are useful for further characterization of the
FIPV entry process. Unravelling this mechanism may lead
to new targets for drug development.
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